Skip to main content
SpringerLink
Log in

Adjuvant Transcatheter Arterial Chemoembolization for Intrahepatic Cholangiocarcinoma after Curative Surgery: Retrospective Control Study

  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

Background

Effects of adjuvant transcatheter arterial chemoembolization (TACE) for intrahepatic cholangiocarcinoma (ICC) radical surgery have never been evaluated.

Methods

A retrospective analysis was conducted on 125 ICC patients who had undergone operations with curative intent in Shanghai Eastern Hepatobiliary Surgery Hospital from July 2002 to December 2003. Of these patients, 53 underwent adjuvant TACE (TACE group) and 72 did not (non-TACE group). Adjuvant TACE was performed one time 1.5–2.0 months after the operation.

Results

Follow-up was performed at a median of 18 months (range 3–96 months). There was no significant recurrence-free survival (RFS) difference between the TACE and non-TACE groups (P = 0.659). The 1-, 3-, and 5-year overall survival (OS) rates were 69.8, 37.7, and 28.3%, respectively, for the TACE group and 54.2, 25.0, and 20.8%, respectively, for the non-TACE group (P = 0.045). Among 54 patients with a recurrence time of ≤3 months, the OS rate of the TACE group was better than that of the non-TACE group (P < 0.001). For 59 patients with a recurrence time later than the median RFS, no significant RFS difference was found between the TACE and non-TACE groups (P = 0.681). These results indicate that TACE could not delay recurrence but could prolong the OS of patients with early recurrence.

Conclusions

Adjuvant TACE after radical surgery was associated with better survival among the ICC patients with early recurrence.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Shin HR, Oh JK, Masuyer E et al (2010) Epidemiology of cholangiocarcinoma: an update focusing on risk factors. Cancer Sci 101:579–585

    Article  PubMed  CAS  Google Scholar 

  2. Lee TY, Lee SS, Jung SW et al (2008) Hepatitis B virus infection and intrahepatic cholangiocarcinoma in Korea: a case-control study. Am J Gastroenterol 103:1716–1720

    Article  PubMed  Google Scholar 

  3. Zhou YM, Yin ZF, Yang JM et al (2008) Risk factors for intrahepatic cholangiocarcinoma: a case-control study in China. World J Gastroenterol 14:632–635

    Article  PubMed  Google Scholar 

  4. Donato F, Gelatti U, Tagger A et al (2001) Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: a case-control study in Italy. Cancer Causes Control 12:959–964

    Article  PubMed  CAS  Google Scholar 

  5. Park J, Kim MH, Kim KP et al (2009) Natural history and prognostic factors of advanced cholangiocarcinoma without surgery, chemotherapy, or radiotherapy: a large-scale observational study. Gut Liver 3:298–305

    Article  PubMed  CAS  Google Scholar 

  6. Jonas S, Thelen A, Benckert C et al (2009) Extended liver resection for intrahepatic cholangiocarcinoma: a comparison of the prognostic accuracy of the fifth and sixth editions of the TNM classification. Ann Surg 249:303–309

    Article  PubMed  Google Scholar 

  7. Lang H, Sotiropoulos GC, Sgourakis G et al (2009) Operations for intrahepatic cholangiocarcinoma: single-institution experience of 158 patients. J Am Coll Surg 208:218–228

    Article  PubMed  Google Scholar 

  8. Jarnagin WR, Shoup M (2004) Surgical management of cholangiocarcinoma. Semin Liver Dis 24:189–199

    Article  PubMed  Google Scholar 

  9. DeOliveira ML, Cunningham SC, Cameron JL et al (2007) Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg 245:755–762

    Article  PubMed  Google Scholar 

  10. Robles R, Figueras J, Turrión VS et al (2004) Spanish experience in liver transplantation for hilar and peripheral cholangiocarcinoma. Ann Surg 239:265–271

    Article  PubMed  Google Scholar 

  11. Sotiropoulos GC, Kaiser GM, Lang H et al (2008) Liver transplantation as a primary indication for intrahepatic cholangiocarcinoma: a single-center experience. Transplant Proc 40:3194–3195

    Article  PubMed  CAS  Google Scholar 

  12. Petrowsky H, Hong JC (2009) Current surgical management of hilar and intrahepatic cholangiocarcinoma: the role of resection and orthotopic liver transplantation. Transplant Proc 41:4023–4035

    Article  PubMed  CAS  Google Scholar 

  13. Mosconi S, Beretta GD, Labianca R (2009) Cholangiocarcinoma. Crit Rev Oncol Hematol 69:259–270

    Article  PubMed  Google Scholar 

  14. Thongprasert S (2005) The role of chemotherapy in cholangiocarcinoma. Ann Oncol 16:93–96

    Google Scholar 

  15. Eckel F, Schmid RM (2007) Chemotherapy in advanced biliary tract carcinoma: a pooled analysis of clinical trials. Br J Cancer 96:896–902

    Article  PubMed  CAS  Google Scholar 

  16. Herber S, Otto G, Schneider J et al (2007) Transarterial chemoembolization (TACE) for inoperable intrahepatic cholangiocarcinoma. Cardiovasc Intervent Radiol 30:1156–1165

    Article  PubMed  CAS  Google Scholar 

  17. Takada T, Amano H, Yasuda H et al (2002) Study Group of Surgical Adjuvant Therapy for Carcinomas of the Pancreas and Biliary Tract: is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma. Cancer 95:1685–1695

    Article  PubMed  Google Scholar 

  18. Jan YY, Yeh CN, Yeh TS (2005) Prognostic analysis of surgical treatment of peripheral cholangiocarcinoma: two decades of experience at Chang Gung Memorial Hospital. World J Gastroenterol 11:1779–1784

    PubMed  Google Scholar 

  19. Nathan H, Pawlik TM (2010) Staging of intrahepatic cholangiocarcinoma. Curr Opin Gastroenterol 26:269–273

    Article  PubMed  CAS  Google Scholar 

  20. Sano T, Kamiya J, Nagino M et al (1999) Macroscopic classification and preoperative diagnosis of intrahepatic cholangiocarcinoma in Japan. J Hepatobiliary Pancreat Surg 6:101–107

    Article  PubMed  CAS  Google Scholar 

  21. Morimoto Y, Tanaka Y, Ito T et al (2003) Long-term survival and prognostic factors in the surgical treatment for intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Surg 10:432–440

    Article  PubMed  Google Scholar 

  22. Shimada K, Sano T, Sakamoto Y (2007) Surgical outcomes of the mass-forming plus periductal infiltrating types of intrahepatic cholangiocarcinoma: a comparative study with the typical mass-forming type of intrahepatic cholangiocarcinoma. World J Surg 31:2016–2022. doi:10.1007/s00268-007-9194-0

    Article  PubMed  Google Scholar 

  23. Paik KY, Jung JC, Heo JS (2008) What prognostic factors are important for resected intrahepatic cholangiocarcinoma? J Gastroenterol Hepatol 23:766–770

    Article  PubMed  Google Scholar 

  24. Tamandl D, Herberger B, Gruenberger B (2008) Influence of hepatic resection margin on recurrence and survival in intrahepatic cholangiocarcinoma. Ann Surg Oncol 15:2787–2794

    Article  PubMed  Google Scholar 

  25. Nakagohri T, Kinoshita T, Konishi M (2008) Surgical outcome and prognostic factors in intrahepatic cholangiocarcinoma. World J Surg 32:2675–2680. doi:10.1007/s00268-008-9778-3

    Article  PubMed  Google Scholar 

  26. Uenishi T, Kubo S, Yamazaki O et al (2008) Indications for surgical treatment of intrahepatic cholangiocarcinoma with lymph node metastases. J Hepatobiliary Pancreat Surg 15:417–422

    Article  PubMed  Google Scholar 

  27. Saiura A, Yamamoto J, Kokudo N et al (2011) Intrahepatic cholangiocarcinoma: analysis of 44 consecutive resected cases including 5 cases with repeat resections. Am J Surg 201:203–208

    Article  PubMed  Google Scholar 

  28. Guglielmi A, Ruzzenente A, Campagnaro T et al (2009) Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection. World J Surg 33:1247–1254. doi:10.1007/s00268-009-9970-0

    Article  PubMed  Google Scholar 

  29. Izumi R, Shimizu K, Iyobe T et al (1994) Postoperative adjuvant hepatic arterial infusion of Lipiodol containing anticancer drugs in patients with hepatocellular carcinoma. Hepatology 20:295–301

    Article  PubMed  CAS  Google Scholar 

  30. Ueno S, Tanabe G, Yoshida A (1999) Postoperative prediction of and strategy for metastatic recurrent hepatocellular carcinoma according to histologic activity of hepatitis. Cancer 86:248–254

    Article  PubMed  CAS  Google Scholar 

  31. Hong C, Guo RP, Li JQ et al (2009) A randomized controlled trial of hepatectomy with adjuvant transcatheter arterial chemoembolization versus hepatectomy alone for stage III A hepatocellular carcinoma. J Cancer Res Clin Oncol 135:1437–1445

    Article  Google Scholar 

  32. Peng BG, He Q, Li JP (2009) Adjuvant transcatheter arterial chemoembolization improves efficacy of hepatectomy for patients with hepatocellular carcinoma and portal vein tumor thrombus. Am J Surg 198:313–318

    Article  PubMed  Google Scholar 

  33. Kelley ST, Bloomston M, Serafini F et al (2004) Cholangiocarcinoma: advocate an aggressive operative approach with adjuvant chemotherapy. Am Surg 70:743–748

    PubMed  CAS  Google Scholar 

  34. Farhat MH, Shamseddine AI, Tawil AN et al (2008) Prognostic factors in patients with advanced cholangiocarcinoma: role of surgery, chemotherapy and body mass index. World J Gastroenterol 14:3224–3230

    Article  PubMed  Google Scholar 

  35. Murakami Y, Uemura K, Sudo T et al (2009) Gemcitabine-based adjuvant chemotherapy improves survival after aggressive surgery for hilar cholangiocarcinoma. J Gastrointest Surg 13:1470–1479

    Article  PubMed  Google Scholar 

  36. Choi SB, Kim KS, Choi JY et al (2009) The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection with survival. Ann Surg Oncol 16:3048–3056

    Article  PubMed  Google Scholar 

  37. Saxena A, Chua TC, Sarkar A (2010) Clinicopathologic and treatment-related factors influencing recurrence and survival after hepatic resection of intrahepatic cholangiocarcinoma: a 19-year experience from an established Australian hepatobiliary unit. J Gastrointest Surg 14:1128–1138

    Article  PubMed  Google Scholar 

  38. Kim JH, Yoon HK, Sung KB et al (2008) Transcatheter arterial chemoembolization or chemoinfusion for unresectable intrahepatic cholangiocarcinoma: clinical efficacy and factors influencing outcomes. Cancer 113:1614–1622

    Article  PubMed  Google Scholar 

  39. Burger I, Hong K, Schulick R et al (2005) Transcatheter arterial chemoembolization in unresectable cholangiocarcinoma: initial experience in a single institution. J Vasc Interv Radiol 16:353–361

    Article  PubMed  Google Scholar 

  40. Hezel AF, Zhu AX (2008) Systemic therapy for biliary tract cancers. Oncologist 13:415–423

    Article  PubMed  CAS  Google Scholar 

  41. Valle J, Wasan H, Palmer DH et al (2010) ABC-02 Trial Investigators: cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med 362:1273–1281

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgment

The Shanghai Natural Science Foundation provided support for this study (no. 09ZR1401100).

Conflicts of interest

None.

Author information

Authors and Affiliations

  1. Department of Special Treatment, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, 225 Changhai Road, Shanghai, 200438, China

    W. F. Shen, Q. Liu, C. J. Sui, Y. Q. Huang & J. M. Yang

  2. Department of Gastroenterology, Changzheng Hospital, Second Military Medical University, 415 Fengyang Road, Shanghai, 200003, China

    W. Zhong

Authors
  1. W. F. Shen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. W. Zhong
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Q. Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C. J. Sui
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Y. Q. Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. J. M. Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J. M. Yang.

Additional information

The first three authors contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shen, W.F., Zhong, W., Liu, Q. et al. Adjuvant Transcatheter Arterial Chemoembolization for Intrahepatic Cholangiocarcinoma after Curative Surgery: Retrospective Control Study. World J Surg 35, 2083–2091 (2011). https://doi.org/10.1007/s00268-011-1171-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-011-1171-y

Keywords

Search

Navigation